期刊文献+

三氧化二砷脂质体治疗大鼠_6脑胶质瘤的实验研究 被引量:3

Experimental study of As_2O_3 liposomes for the treatment of C_6 glioma in rats
下载PDF
导出
摘要 目的研究三氧化二砷(As_2O_3)脂质体对荷瘤大鼠血脑屏障(BBB)的透过率及其对大鼠脑胶质瘤的生长抑制作用。方法应用超声薄膜分散法制备As_2O_3脂质体,检测其包封率;建立大鼠脑胶质瘤模型,分别给予As_2O_3脂质体和As_2O_3,应用原子荧光法检测给药后大鼠脑组织中的砷浓度,以判定其对血脑屏障的透过性,并与给予生理盐水的对照组相比,从电镜、TUNNEL、MRI影像及大鼠的生存状态等方面研究As_2O_3脂质体对C_6胶质瘤的影响。结果 As_2O_3脂质体组砷的血脑屏障透过性明显提高,电镜及TUNEL法检测示肿瘤细胞凋亡率(20.03%)高于其他2组(3.92%、4.09%);大鼠中位生存时间(70d)优于生理盐水组(21d)和As_2O_3组(23d)。结论 As_2O_3脂质体可以明显提高鼠脑内As_2O_3浓度,并能诱导胶质瘤细胞的凋亡,抑制大鼠脑胶质瘤的生长,从而延长荷瘤大鼠的生存时间。 Objective To investigate the permeation rate of As 2 O3 liposomes passing blood brain barrier (BBB) in tumor‐bearing rats and its inhibition effect on the C 6 glioma growth in vivo.Methods The As2 O3 liposomes were developed by film‐ul‐trasonic wave dispersion method and the encapsulation efficiency was performed. Then all rats were intravenously injected by As2 O3 liposomes and As2 O3 respectively after successfully establishing the glioma models in rats. After that ,As2 O3 concentra‐tion of brain tissue was measured using atomic fluorescence technique to assess permeability of blood brain barrier . Compared with controls injected by normal saline ,we studied the effect of As2 O3 liposomes on C6 glioma from the following aspects inclu‐ding electron microscopy ,TUNNEL staining ,Magnetic Resonance Imaging (MRI) and the survival condition. Results The As2 O3 liposomes could obviously facilitate permeability of blood brain barrier. The results of electronic microscopic analysis and TUNNEL staining showed that the apoptosis rate (20.03% ) of tumor cells in As2 O3 liposomes group was much higher than that in the other two groups (3.92% ,4.09% ). As2 O3 liposomes group had longer median survival time of 70 days than 21 days in the saline group and 23 days in As2 O3 group.Conclusion The As2 O3 liposomes can significantly improve the As2 O3 concentration of rats'brain ,and can induce apoptosis in glioma cells and suppress intracranial tumor growth and prolong the life span of tumor‐bearing rats.
出处 《中国实用神经疾病杂志》 2015年第24期1-3,共3页 Chinese Journal of Practical Nervous Diseases
基金 黑龙江省自然科学基金项目资助(编号:D201155)
关键词 三氧化二砷 脂质体 神经胶质瘤 细胞凋亡 As2O3 Liposome Glioma Apoptosis
  • 相关文献

参考文献9

  • 1Marija Glavas-Dodov,Emilija Fredre-Kumbaradi,Katerina Goracinova, et a1.5-Fluorouracil in topical liposome gels for anticancer treatment formulation and evaluation. Acta Pharmaceutica . 2003
  • 2Kim Jae Ho,Lew Young S,Kolozsvary Andrew,Ryu Samuel,Brown Stephen L.Arsenic trioxide enhances radiation response of 9L glioma in the rat brain. Radiation Research . 2003
  • 3Nancy D. Doolittle,Lauren E. Abrey,W. Archie Bleyer,Steven Brem,Thomas P. Davis,Paula Dore-Duffy,Lester R. Drewes,Walter A. Hall,John M. Hoffman,Agnieszka Korfel,Robert Martuza,Leslie L. Muldoon,David Peereboom,Darryl R. Peterson.New Frontiers in Translational Research in Neuro-oncology and the Blood-Brain Barrier: Report of the Tenth Annual Blood-Brain Barrier Disruption Consortium Meeting. Clinical Cancer Research . 2005
  • 4William M. Pardridge.??Vector-mediated drug delivery to the brain(J)Advanced Drug Delivery Reviews . 1999 (2)
  • 5Shiguang Zhao,Takahiro Tsuchida,Katsuhiro Kawakami,Changbin Shi,Keiji Kawamoto.??Effect of As2O3 on cell cycle progression and cyclins D1 and B1 expressionin two glioblastoma cell lines differing in p53 status(J)International Journal of Oncology . 2002 (1)
  • 6陈忠平.脑胶质瘤的综合治疗[J].实用临床医药杂志,2004,8(1):38-40. 被引量:5
  • 7赵世光,李力仙,张建华,叶远柱,甄云波,滕雷,邹慧超,刘恩重,河本圭司.As_2O_3对不同p53表型的人胶质瘤细胞系细胞周期蛋白B_1、D_1表达的影响[J].中华神经外科杂志,2004,20(3):202-206. 被引量:19
  • 8李明,冯华,李飞,王宪荣,吴南,陈志,吴国材,卢佳友,林江凯.大鼠C6脑胶质瘤模型的病理特征与MRI的观察[J].中华神经外科杂志,2005,21(5):279-282. 被引量:37
  • 9赵世光,滕雷,赵洪波,刘耀华,甄云波,张娜,唐海涛,杨宝峰.荧光引导鼠脑胶质瘤切除的实验研究[J].中华神经外科杂志,2006,22(2):120-122. 被引量:32

二级参考文献40

  • 1陈忠平,周旺宁,赛克.循证医学在神经肿瘤治疗中的应用[J].中国神经肿瘤杂志,2003,1(1):53-58. 被引量:2
  • 2陈忠平,赛克.神经外科医生在手术切除脑肿瘤的同时还能做些什么?[J].中国神经肿瘤杂志,2003,1(3):129-133. 被引量:3
  • 3李晓楠 杜子威 黄强 见:黄强主编 陈忠平 兰青副主编.肿瘤促分化治疗[A].见:黄强主编,陈忠平,兰青副主编.脑肿瘤分子外科学[C].北京:中国科技出版社,1998.70.
  • 4Puzzilli F, Ruggeri A, Mastronardi L, et al. Long-term survival in cerebral glioblastoma[J]. Tumori, 1998, 84(1): 69.
  • 5Stewart L A. Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trials[J]. Lancet, 2002, 359(9311): 1011.
  • 6Mikkelsen T. Cytostatie agents in the management of malignant gliomas[J]. Cancer Control, 1998, 5: 150.
  • 7Rutka J T, Taylor M, Mainprize T, et al. Molecular biology and neurosurgery in the third millennium[J]. Neurosurgery.2000, 46(5): 1034.
  • 8Gutin P H, Posner J B. Neuro-oncology.: Dimaosis mad management of cerebral glioma-past, present, and future. Neurosurgery., 2000, 47(1): 1.
  • 9Moore GE, Peyton WT, French LA, et al.The clinical use of fluorescein in neurosurgery. The localization of brain tumors. J Neurosurg, 1948, 5: 392-398.
  • 10Toshihiko K, Yoshinaga K, Tomio O, et al. Development of a fluorescein operative microscope for use during malignant glioma surgery. Surg Neurol, 1998, 50: 41-48.

共引文献88

同被引文献64

  • 1Ostrom QT, Gittleman H, Fulop J, et al. CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2008-2012 [J]. Neuro Oncol, 2015, 17 Suppl 4: ivl-iv62, doi: 10,1093/neuonc/nov189.
  • 2Ellis HP, Greenslade M, Powell B, et al. Current Challenges in Glioblastoma: Intratumour Heterogeneity, Residual Dis- ease, and Models to Predict Disease Recurrence [J]. Front Oncol, 2015, 5: 251. doi: 10.3389/fonc,2015.00251.
  • 3Lima FR, Kahn SA, Soletti RC, et al. Glioblastoma: therapeutic challenges, what lies ahead [J]. Biochim Biophys Acta, 2012, 1826(2): 338-349. doi: 10,1016/ j.bbcan,2012.05.004.
  • 4Champ CE, Siglin J, Mishra MV, et al. Evaluating changes in radiation treatment volumes from post-operative to same- day planning MRI in High-grade gliomas [J]. Radiat Oncol, 2012, 7: 220. doi: 10,1186/1748-717X-7-220.
  • 5Chen S, Tanaka S, Giannini C, et al. Gliomatosis cerebri: clinical characteristics, management, and outcomes [J]. J Neurooncol, 2013, 112(2): 267-275. doi: 10,1007/sl 1060- 013-1058-x.
  • 6Zhan C, Li B, Hu L, et al. Micelle-based brain-targeted drug delivery enabled by a nicotine acetylcholine recep- tor ligand [J]. Angew Chem Int Ed Engl, 2011, 50(24): 5482-5485. doi: 10,1002/anie,201100875.
  • 7Lu W, Wan J, She Z, et al. Brain delivery property and ac- celerated blood clearance of cationic albumin conjugated pegylated nanoparticle [J]. J Control Release, 2007, 118(1): 38-53.
  • 8Bolhassani A. Potential efficacy of cell-penetrating peptides for nucleic acid and drug delivery in cancer [J]. Biochim Biophys Acta, 2011, 1816(2): 232-246. doi: 10,1016/ j.bbcan,2011.07.006.
  • 9Chen X, Plasencia C, Hou Y, et al. Synthesis and biological evaluation of dimeric RGD peptide-paclitaxel conjugate as a model for integrin-targeted drug delivery [J]. J Med Chem, 2005, 48(4): 1098-1106.
  • 10Zhan C, Gu B, Xie C, et al. Cyclic RGD conjugated poly(ethylene glycol)-co-poly(lactic acid) micelle enhances paclitaxel anti-glioblastoma effect [J]. J Control Release, 2010, 143(1): 136-142. doi: 10,1016/j.jconrel,2009,12.020.

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部